171 related articles for article (PubMed ID: 30563528)
1. Use of Bayesian methods to model the SF-6D health state preference based data.
Kharroubi SA
Health Qual Life Outcomes; 2018 Dec; 16(1):234. PubMed ID: 30563528
[TBL] [Abstract][Full Text] [Related]
2. Modelling a preference-based index for EQ-5D-3L and EQ-5D-3L + Sleep using a Bayesian framework.
Kharroubi SA; Beyh YS; Brazier J; Yang Y
Qual Life Res; 2020 Jun; 29(6):1495-1507. PubMed ID: 32016681
[TBL] [Abstract][Full Text] [Related]
3. The Importance of Accounting for Parameter Uncertainty in SF-6D Value Sets and Its Impact on Studies that Use the SF-6D to Measure Health Utility.
Kharroubi SA; Beyh Y; Abdul Fattah E; Young T
Int J Environ Res Public Health; 2020 Jun; 17(11):. PubMed ID: 32498412
[TBL] [Abstract][Full Text] [Related]
4. Modelling SF-6D health state preference data using a nonparametric Bayesian method.
Kharroubi SA; Brazier JE; Roberts J; O'Hagan A
J Health Econ; 2007 May; 26(3):597-612. PubMed ID: 17069909
[TBL] [Abstract][Full Text] [Related]
5. Analysis of SF-6D Health State Utility Scores: Is Beta Regression Appropriate?
Kharroubi SA
Healthcare (Basel); 2020 Dec; 8(4):. PubMed ID: 33271844
[No Abstract] [Full Text] [Related]
6. Estimating the SF-6D value set for a population-based sample of Brazilians.
Cruz LN; Camey SA; Hoffmann JF; Rowen D; Brazier JE; Fleck MP; Polanczyk CA
Value Health; 2011; 14(5 Suppl 1):S108-14. PubMed ID: 21839880
[TBL] [Abstract][Full Text] [Related]
7. Mapping chronic liver disease questionnaire scores onto SF-6D utility values in patients with primary sclerosing cholangitis.
Kalaitzakis E; Benito de Valle M; Rahman M; Lindkvist B; Björnsson E; Chapman R; Kontodimopoulos N
Qual Life Res; 2016 Apr; 25(4):947-57. PubMed ID: 26471264
[TBL] [Abstract][Full Text] [Related]
8. A comparison of Hong Kong and United Kingdom SF-6D health states valuations using a nonparametric Bayesian method.
Kharroubi SA; Brazier JE; McGhee S
Value Health; 2014 Jun; 17(4):397-405. PubMed ID: 24969000
[TBL] [Abstract][Full Text] [Related]
9. The development of a model for translation of the Neck Disability Index to utility scores for cost-utility analysis in cervical disorders.
Richardson SS; Berven S
Spine J; 2012 Jan; 12(1):55-62. PubMed ID: 22209244
[TBL] [Abstract][Full Text] [Related]
10. A Bayesian Nonparametric Approach for Modeling SF-6D Health State Utility Scores.
Kharroubi SA
Value Health Reg Issues; 2022; 27():1-11. PubMed ID: 34784542
[TBL] [Abstract][Full Text] [Related]
11. Mapping the cancer-specific EORTC QLQ-C30 to the preference-based EQ-5D, SF-6D, and 15D instruments.
Kontodimopoulos N; Aletras VH; Paliouras D; Niakas D
Value Health; 2009; 12(8):1151-7. PubMed ID: 19558372
[TBL] [Abstract][Full Text] [Related]
12. Unchained melody: revisiting the estimation of SF-6D values.
Craig BM
Eur J Health Econ; 2016 Sep; 17(7):865-73. PubMed ID: 26359242
[TBL] [Abstract][Full Text] [Related]
13. Using the Multiple Sclerosis Impact Scale to estimate health state utility values: mapping from the MSIS-29, version 2, to the EQ-5D and the SF-6D.
Hawton A; Green C; Telford C; Zajicek J; Wright D
Value Health; 2012 Dec; 15(8):1084-91. PubMed ID: 23244811
[TBL] [Abstract][Full Text] [Related]
14. Modeling SF-6D Health Utilities: Is Bayesian Approach Appropriate?
Kharroubi SA
Int J Environ Res Public Health; 2021 Aug; 18(16):. PubMed ID: 34444157
[TBL] [Abstract][Full Text] [Related]
15. A Portuguese value set for the SF-6D.
Ferreira LN; Ferreira PL; Pereira LN; Brazier J; Rowen D
Value Health; 2010 Aug; 13(5):624-30. PubMed ID: 20230545
[TBL] [Abstract][Full Text] [Related]
16. Testing alternative regression models to predict utilities: mapping the QLQ-C30 onto the EQ-5D-5L and the SF-6D.
Lamu AN; Olsen JA
Qual Life Res; 2018 Nov; 27(11):2823-2839. PubMed ID: 30173314
[TBL] [Abstract][Full Text] [Related]
17. Valuing SF-6D Health States Using a Discrete Choice Experiment.
Norman R; Viney R; Brazier J; Burgess L; Cronin P; King M; Ratcliffe J; Street D
Med Decis Making; 2014 Aug; 34(6):773-86. PubMed ID: 24025661
[TBL] [Abstract][Full Text] [Related]
18. Modeling SF-6D Hong Kong standard gamble health state preference data using a nonparametric Bayesian method.
Kharroubi SA; Brazier JE; McGhee S
Value Health; 2013; 16(6):1032-45. PubMed ID: 24041353
[TBL] [Abstract][Full Text] [Related]
19. Obtaining SF-6D utilities from FACT-H&N in thyroid carcinoma patients: development and results from a mapping study.
Yang Q; Huang D; Jiang L; Tang Y; Zeng D
Front Endocrinol (Lausanne); 2023; 14():1160882. PubMed ID: 37664851
[TBL] [Abstract][Full Text] [Related]
20. Valuation of preference-based measures: can existing preference data be used to generate better estimates?
Kharroubi SA
Health Qual Life Outcomes; 2018 Jun; 16(1):116. PubMed ID: 29866108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
